Bromantane · Research brief

Is Bromantane Legal? Research-Use-Only Status Explained

Real Peptides Research TeamEditorial

Updated September 9, 202611 min read

56 WORDS

Short answer

Bromantane is not a scheduled controlled substance under federal law. Vendors lean on that sentence hard, because it lets them imply something the law never said. Not being scheduled is a completely different thing from being lawful to sell for human consumption, and the entire bromantane legal picture lives in the gap between those two ideas.

Key takeaways

Bromantane is not listed on any of the five federal controlled substance schedules, which is why it can be supplied lawfully as a research-use-only chemical.
Bromantane legal status as a dietary supplement does not exist, because it lacks pre-1994 marketing history and has no accepted 75-day new dietary ingredient notification.
Under the Federal Food, Drug, and Cosmetic Act, intended use rather than molecular structure determines whether a product is a drug, so marketing claims alone can convert a legal research chemical into an unapproved new drug.
Bromantane has been prohibited in competitive sport since 1997, and anti-doping rules operate entirely independently of the bromantane legal position under federal law.
Published human pharmacokinetic parameters for bromantane are not well established in the peer-reviewed English-language literature, so any vendor quoting a precise half-life is guessing.
A certificate of analysis reporting identity by mass spectrometry and purity by HPLC for a named lot is the only meaningful proof of what is in a research vial.

We supply research-grade compounds to laboratories and academic groups, and the bromantane legal question lands in our inbox constantly. Almost everyone who asks has already read the same forum half-answer, and that half-answer is exactly what gets buyers into trouble with customs, payment processors, and their own compliance office.

Is bromantane legal?

Bromantane appears on no federal controlled substance schedule, but it is also not an approved drug and not a lawful dietary ingredient, which is why legitimate suppliers offer it research-use-only. Under the Federal Food, Drug, and Cosmetic Act of 1938, marketing it for people to take converts it into an unapproved new drug.

The oversimplification worth killing early: unscheduled does not mean approved, and it certainly doesn't mean sellable for consumption. Three separate federal frameworks apply to a compound like this simultaneously, and a product can sit cleanly outside one while flatly violating another. This article covers what research-use-only labeling actually restricts, how the bromantane legal analysis differs under drug law versus supplement law, why marketing language alone can reclassify a molecule, and what documentation a research buyer should insist on before wiring money.

What research-use-only actually means on a label

Research-use-only (RUO) is a use restriction, not a safety rating. The label says the material is intended for in vitro laboratory investigation by qualified personnel, and that it is not for diagnostic, therapeutic, human, or veterinary use. It is the honest description of a compound that has never completed an approval pathway, which is precisely why bromantane legal status defaults to that category rather than to anything more permissive.

Bromantane, chemically N-(2-adamantyl)-N-(4-bromophenyl)amine and sometimes referred to as ladasten in older literature, was developed during the late Soviet period as an actoprotector. That's a compound class studied for maintaining physical and mental work capacity under stress, immunological load, or heat, rather than for treating a defined disease. Preclinical research in rodent models reports that it influences dopamine biosynthesis by increasing expression of tyrosine hydroxylase, the rate-limiting enzyme that converts tyrosine into L-DOPA, alongside reported anxiolytic and immunomodulatory effects.

Here's where we stay honest: the English-language human pharmacokinetic literature on bromantane is thin. Peer-reviewed half-life, bioavailability, and clearance figures are not consistently established, so we don't quote them and you should distrust any vendor page that does. A specific number attached to a compound with no completed clinical program is a marketing decision, not a pharmacology finding.

Our team reviews certificates of analysis across dozens of research compounds every month, and the pattern is consistent. The vendors most willing to invent pharmacokinetic specifics are the same ones least willing to produce a lot-specific purity report. The bromantane legal risk and the quality risk travel together.

Is bromantane legal to buy, sell, or ship for laboratory use?

Yes, as an unscheduled chemical supplied for bona fide research it can be bought and sold, provided nobody in the chain markets it for consumption. The bromantane legal analysis rests on three statutes working in parallel.

First, the Controlled Substances Act. It places regulated drugs into one of five federal schedules, and bromantane is listed on none of them as of 2026. The Controlled Substance Analogue Enforcement Act of 1986 extends coverage to analogues of Schedule I and II substances, and bromantane's adamantane-plus-bromophenyl structure has not been treated as such an analogue. No DEA registration is triggered.

Second, the Dietary Supplement Health and Education Act of 1994. A lawful dietary ingredient must either have been marketed before October 1994 or clear a new dietary ingredient notification submitted to the FDA at least 75 days before sale. Bromantane satisfies neither route, so bromantane legal status as a supplement simply does not exist. Any capsule bottle claiming otherwise is a labeling violation dressed up as a loophole.

Third, drug law. Anything sold with claims about energy, focus, mood, or endurance becomes a drug by intended use, regardless of what the powder is.

One more layer people forget: sport. Bromantane has been prohibited in competition since 1997, following positive tests at the 1996 Olympic Games, and anti-doping eligibility operates independently of any bromantane legal question at the federal level. This article is regulatory education, not legal advice, and jurisdiction-specific questions belong with qualified counsel.

The gap between unscheduled and lawful to sell

The single most misunderstood point in this whole area: the molecule does not determine legality, the claim does. Under the Federal Food, Drug, and Cosmetic Act's definition of a drug, a product's classification turns on its intended use, and intended use is proven by evidence of what the seller communicated. That means the identical vial of powder can be a lawful research chemical on Monday and misbranded, unapproved new drug on Tuesday, with nothing changing except website copy.

Evidence of intended use is broader than most sellers realise. It includes product page text, testimonials, blog content, customer service replies, social posts, dosing charts, product tags, and even the search terms a vendor pays for. Bromantane legal classification collapses the moment a supplier adds a milligram suggestion or a before-and-after story, because the agency reads the whole context, not just the disclaimer at the bottom of the page.

This is why the RUO disclaimer buried under a page full of nootropic benefit claims provides no protection at all. It contradicts the rest of the site, and contradiction is exactly what enforcement letters in the research chemical space cite.

For a buyer, the practical consequence is uncomfortable but simple. Purchasing from a vendor that markets consumption claims imports that vendor's regulatory exposure into your own paper trail, because your order sits alongside their marketing in any review. A clean bromantane legal position depends as much on who you buy from as on what you buy.

What compliant sourcing documentation looks like

The practical problem with unscheduled research compounds isn't the schedule, it's identity. Nothing in an unscheduled status requires a seller to prove the contents of the vial, and misidentified or under-purity material is the most common failure we see reported across the research chemical market.

The mechanism that closes that gap is lot-level analytical verification. A usable certificate of analysis names the compound, states the lot number and analysis date, and reports identity by mass spectrometry alongside purity by HPLC for that specific batch. A generic PDF with no lot number is a brochure, not a COA. Handling matters too, and here's a distinction that trips people up constantly: bromantane is a small-molecule adamantane derivative, not a peptide, so the cold-chain and reconstitution rules that govern lyophilised peptide storage don't map onto it directly.

Our own catalog is peptides rather than small molecules, and it does not include bromantane. What transfers is the documentation standard: small-batch synthesis, exact amino-acid sequencing, and a certificate of analysis with every lot, which is the same evidentiary bar any bromantane legal file should meet. You can see how that documentation is presented across our research catalog and hold other suppliers to it.

One clarification that belongs here: research-use-only compounds are not for human or veterinary administration, and anyone with a health question about an animal should talk to their veterinarian rather than sourcing a research chemical.

Bromantane legal status compared with other regulatory categories

Most confusion comes from collapsing five separate categories into one word, legal. This table separates them so you can see exactly which framework bromantane falls under and which it doesn't.

Regulatory category	What the category legally means	Where bromantane sits	Bottom line for a research buyer
Controlled substance (Controlled Substances Act)	Placed into one of five federal schedules, with DEA registration and recordkeeping required for research access	Not listed on any federal schedule as of 2026	No DEA registration is triggered, and this is the single fact vendors most often overstate
Approved prescription drug	Cleared through a federal application reviewing manufacturing, labeling, and clinical evidence	No federal approval; reported approval as a prescription medicine in at least one other jurisdiction does not transfer	Treat it as an unapproved new drug, because foreign approval carries no federal weight
Dietary ingredient (DSHEA 1994)	Must have pre-1994 marketing history or clear a 75-day new dietary ingredient notification	Neither route satisfied, so it is not a lawful dietary ingredient	Any supplement bottle is a labeling violation, not a legitimate consumer channel
Research-use-only chemical	Supplied for in vitro laboratory investigation by qualified personnel, never for human, veterinary, diagnostic, or therapeutic use	The only category the compound currently fits	Buy with a lot-specific COA and keep your intended use documented in writing
Prohibited in sport (WADA)	Banned in competition regardless of national legality	Prohibited since 1997 after positive tests at the 1996 Olympic Games	Legality and athletic eligibility are separate systems, and one does not protect you from the other

What If: Bromantane Compliance Scenarios

What if a vendor sells bromantane labeled as a dietary supplement?

Treat that listing as a red flag and source elsewhere. A supplement label on a compound with no lawful dietary ingredient pathway means the seller has already accepted regulatory exposure, and buyers inherit part of that exposure through their order records. It also signals the vendor's priorities: sites willing to misclassify a product are rarely the ones investing in lot-level analytical testing. The bromantane legal framing on the label is the cheapest possible tell about everything behind it.

What if my shipment is detained or returned?

Expect the carrier or agency to request documentation of the material's identity and intended use, and be able to produce it immediately. Unscheduled status does not exempt a shipment from inspection, and detentions in the research chemical space commonly turn on paperwork rather than the compound itself. A purchase order naming the research application, plus a lot-specific certificate of analysis, resolves most identity questions. Import determinations vary by shipment and by jurisdiction, so route genuine disputes to counsel rather than to a customer service chat.

What if my institution's compliance office asks how the material is classified?

Give them the three-part answer: unscheduled under the Controlled Substances Act, not an approved drug, not a lawful dietary ingredient, therefore research-use-only. That framing maps directly onto the questions an institutional review or purchasing committee asks, and it avoids the vague not illegal phrasing that stalls approvals. Attach the COA and the supplier's RUO statement to the request. Documented bromantane legal reasoning moves through compliance far faster than an assurance that nobody has banned it yet.

What if bromantane gets scheduled in the future?

Assume it's possible and keep records that would survive the change. Scheduling actions and import alerts in this category tend to arrive with little warning, and material lawfully purchased beforehand can become a registration problem overnight. Labs that log lot numbers, quantities, storage location, and disposal are positioned to respond; labs with a drawer of unlabelled vials are not. Nothing here predicts a specific outcome, and a compliance decision of that weight belongs with your counsel.

The unglamorous truth about grey-market sourcing

Let's be direct about this: most people searching whether bromantane is legal are not asking a regulatory question, they're looking for permission. The honest answer is that research-use-only status is a genuine legal category with genuine limits, not a wink. The compound has no completed federal approval program, its human data is thin enough that reputable suppliers won't quote parameters, and the sellers most eager to reassure you are the ones publishing the claims that create liability in the first place. Bromantane legal for laboratory research is true. Bromantane legal for consumption is not a thing, and no disclaimer font size changes that.

The bromantane legal answer that actually matters isn't yes or no, it's a question about intent, and intent is the one variable a buyer controls completely. Regulators read context: the invoice, the label, the marketing, the stated purpose. Two people can order the same vial from the same supplier and end up in entirely different regulatory positions based on nothing but what they wrote down and what they claimed. Before you evaluate the compound, evaluate the paperwork around it, because that paper trail is what any reviewer will read first.

References

Peer-reviewed sources on Bromantane indexed in PubMed, listed for research context. Real Peptides supplies Bromantane for laboratory research use only.

Correcting effect of ladasten on variations in the subpopulation composition of T lymphocytes in C57BL/6 mice on the experimental model of an anxious-depressive state. Bulletin of experimental biology and medicine, 2014. PMID 24771370. doi:10.1007/s10517-014-2343-1
[Ladasten versus placebo effect self-evaluated by neurasthenia patients with different EEG alpha rhythm types]. Eksperimental'naia i klinicheskaia farmakologiia, 2012. PMID 22834121
Mechanisms of action of ladasten: activation of gene expression for neurotrophins and mitogen-activated kinases. Bulletin of experimental biology and medicine, 2012. PMID 22803074. doi:10.1007/s10517-012-1516-z
Effect of ladasten on the content of cytokine markers of inflammation and behavior of mice with experimental depression-like syndrome. Bulletin of experimental biology and medicine, 2011. PMID 22803040. doi:10.1007/s10517-011-1453-2
[Effect of antiasthenic drug ladasten on the level of cytokines and behavior in experimental model of anxious depression in C57BL/6 male mice]. Eksperimental'naia i klinicheskaia farmakologiia, 2011. PMID 22288152
Time course of histone deacetylase 1 and acetylated H3 and H4 histones in the brain of rats treated with ladasten. Bulletin of experimental biology and medicine, 2011. PMID 22235395. doi:10.1007/s10517-011-1201-7
[Role of the brain dopaminergic and serotoninergic systems in psychopharmacological effects of ladasten and sydnocarb]. Eksperimental'naia i klinicheskaia farmakologiia, 2010. PMID 20369592
[Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015]. Eksperimental'naia i klinicheskaia farmakologiia, 2010. PMID 20408420

Questions

Bromantane is not listed on any federal controlled substance schedule, so it can be supplied lawfully as a research-use-only chemical. It is not an approved drug and not a lawful dietary ingredient, which means selling or marketing it for human consumption makes it an unapproved new drug. This is regulatory education, not legal advice.

Structurally the regulatory logic is identical: both sit outside the Controlled Substances Act, neither has federal approval, and both are supplied research-use-only. The practical difference is handling and analysis. Bromantane is a small molecule, while peptides are lyophilised powders with their own cold-chain and reconstitution requirements. Legal category, same. Laboratory protocol, different.

Classification turns on intended use, not chemistry. Under the Federal Food, Drug, and Cosmetic Act, a product becomes a drug when it is intended to affect the structure or function of the body, and that intent is proven with the seller's own evidence: product copy, testimonials, dosing charts, blog content, and advertising terms. The same vial can fall into either category.

Research-use-only material is sold for in vitro laboratory investigation by qualified personnel, which in practice means researchers, institutional labs, and commercial R and D groups that can document a research application. It is never supplied for human, veterinary, diagnostic, or therapeutic use. Many suppliers also require an institutional account or a stated research purpose before releasing an order.

Access runs through research chemical suppliers rather than pharmacies, since there is no approved drug product to prescribe. Pricing varies widely between vendors and depends heavily on purity documentation, batch size, and analytical testing, so published figures are not comparable across suppliers. The meaningful cost variable is whether the price includes lot-specific HPLC and mass spectrometry verification.

The dominant risk is identity, not scheduling. Nothing about unscheduled status obliges a seller to prove what is in the vial, so misidentified compounds, undisclosed impurities, and inaccurate purity claims are the recurring problems in this market. Without a certificate of analysis naming the lot number, analysis date, identity, and purity method, you have no evidence of what you received.

Yes. Bromantane has been prohibited in competition since 1997, following positive tests at the 1996 Olympic Games, and it remains on anti-doping prohibited lists. Anti-doping systems operate independently of national drug law, so an unscheduled compound can still end an athlete's eligibility. Legality and eligibility are two separate questions with two separate answers.

It has not been treated as one. The Controlled Substance Analogue Enforcement Act of 1986 reaches substances substantially similar in structure or effect to Schedule I and II drugs, and bromantane's adamantane plus bromophenyl framework has not been classified under it. Analogue determinations are fact-specific and made case by case, so this is a question for counsel rather than a settled rule.

It has been reported as an approved prescription medicine in at least one non-domestic jurisdiction, where it was developed as an actoprotector. That approval carries no federal weight and does not create any import or sales pathway. For regulatory purposes it remains an unapproved new drug, which is exactly why research-use-only labeling applies.

No. A certificate of analysis verifies identity and purity for a specific lot; it says nothing about approval status or permitted use. Analytical documentation supports research legitimacy and quality assurance, and it is essential for that purpose, but it cannot convert an unapproved compound into something lawful for human or veterinary administration.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA